Yamagiwa, Satoshi <br/><br/>
Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C.  [electronic resource] 

 -  International journal of medical sciences  2017 
 - 403-411 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1449-1907 
<br/><br/><label>Standard No.: </label>10.7150/ijms.18784  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>B7-H1 Antigen--blood<br/>Carcinoma, Hepatocellular--blood<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepatitis C, Chronic--blood<br/>Humans<br/>Interferon-gamma--administration & dosage<br/>Liver Neoplasms--blood<br/>Male<br/>Middle Aged<br/>Oligopeptides--administration & dosage<br/>Ribavirin--administration & dosage<br/>Simeprevir--administration & dosage